1. Home
  2. SNFCA vs GLSI Comparison

SNFCA vs GLSI Comparison

Compare SNFCA & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Security National Financial Corporation

SNFCA

Security National Financial Corporation

N/A

Current Price

$8.79

Market Cap

229.2M

Sector

Finance

ML Signal

N/A

Logo Greenwich LifeSciences Inc.

GLSI

Greenwich LifeSciences Inc.

N/A

Current Price

$17.10

Market Cap

267.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SNFCA
GLSI
Founded
1965
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
229.2M
267.4M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
SNFCA
GLSI
Price
$8.79
$17.10
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $57.00
AVG Volume (30 Days)
21.4K
★ 88.7K
Earning Date
11-12-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 13.51
N/A
EPS
★ 0.60
N/A
Revenue
★ $344,587,538.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.67
★ N/A
Revenue Growth
★ 3.01
N/A
52 Week Low
$7.70
$7.78
52 Week High
$10.23
$34.10

Technical Indicators

Market Signals
Indicator
SNFCA
GLSI
Relative Strength Index (RSI) 44.85 54.23
Support Level $8.51 $17.96
Resistance Level $9.80 $19.97
Average True Range (ATR) 0.16 1.30
MACD 0.02 0.08
Stochastic Oscillator 45.45 55.64

Price Performance

Historical Comparison
SNFCA
GLSI

About SNFCA Security National Financial Corporation

Security National Financial Corp is a holding company providing insurance services. The company operates in three reportable business segments: Life insurance, Cemetery and Mortuary, and Mortgages. The life insurance segment sells and services selected lines of life insurance, annuity products, and accident and health insurance. The cemetery and mortuary segment engages in pre-need selling of funeral, cemetery, mortuary, and cremation services through its cemetery and mortuary locations. The mortgage segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and other real estate projects. It derives the majority of revenue from Life Insurance segment.

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.

Share on Social Networks: